ARCHIVES

In Brief: FCRC Committee Loses Chance To influence RFP; Recompetition To Remain On Schedule

This article is from The Cancer Letter archive.

Vol. 02 No. 45 | November 5, 1976

Download PDF Visit The Full Archive

Related Articles

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992

Conversation with The Cancer Letter: Kazerooni: The Case for Broad Coverage

March 21, 2014

In Brief: NCI, OMB Heading For November Confrontation Over Hawaii, Papanicolaou Construction Funds

October 17, 1975

NCI RFA Available: Minority-Based CCOPS

August 15, 1997

Fermilab Treats 1,000th Patient

August 7, 1981

Tobacco Control: Surgeon General Finds Increase In Smoking By Minority Teens

May 1, 1998